{"id":"androgel-testosterone-gel","safety":{"commonSideEffects":[{"rate":"5-15","effect":"Skin irritation at application site"},{"rate":"5-10","effect":"Acne"},{"rate":"5-10","effect":"Polycythemia (elevated red blood cell count)"},{"rate":"1-5","effect":"Gynecomastia (breast tissue enlargement)"},{"rate":"1-5","effect":"Mood changes/irritability"},{"rate":"1-5","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL1200335","moleculeType":"Small molecule","molecularWeight":"400.60"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Testosterone is absorbed through the skin and enters systemic circulation, where it binds to androgen receptors throughout the body to restore normal male hormone levels. This replacement therapy restores secondary sexual characteristics, muscle mass, bone density, and sexual function in men with clinically low testosterone.","oneSentence":"Androgel delivers testosterone transdermally to replace deficient testosterone levels in hypogonadal men.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:27:14.271Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypogonadism (testosterone deficiency) in adult males"}]},"trialDetails":[{"nctId":"NCT07481942","phase":"","title":"Body Composition Assessment in Transgender Population.","status":"COMPLETED","sponsor":"Celia Bañuls","startDate":"2017-01-01","conditions":"Transgender","enrollment":70},{"nctId":"NCT04675788","phase":"PHASE4","title":"Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening","status":"COMPLETED","sponsor":"Indiana University","startDate":"2021-09-02","conditions":"Long QT Syndrome, Abnormalities, Drug-Induced","enrollment":73},{"nctId":"NCT07142551","phase":"PHASE2","title":"Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response","status":"RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2026-03-09","conditions":"Metastatic Castration-resistant Prostate Cancer","enrollment":60},{"nctId":"NCT06305598","phase":"PHASE1","title":"Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer","status":"RECRUITING","sponsor":"Roswell Park Cancer Institute","startDate":"2024-12-19","conditions":"Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8","enrollment":14},{"nctId":"NCT06733350","phase":"PHASE4","title":"Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance","status":"SUSPENDED","sponsor":"Roswell Park Cancer Institute","startDate":"2025-01-15","conditions":"Localized Prostate Carcinoma, Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8","enrollment":600},{"nctId":"NCT06059118","phase":"PHASE2","title":"Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer","status":"RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2023-10-04","conditions":"Prostate Cancer","enrollment":50},{"nctId":"NCT06130449","phase":"EARLY_PHASE1","title":"Testosterone and Neural Function","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2024-04-01","conditions":"Spinal Cord Injury","enrollment":15},{"nctId":"NCT06084338","phase":"PHASE2","title":"Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2023-12-14","conditions":"Prostate Cancer","enrollment":60},{"nctId":"NCT03887936","phase":"PHASE4","title":"Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism","status":"ACTIVE_NOT_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2019-10-01","conditions":"Type 2 Diabetes Mellitus, Hypogonadism","enrollment":92},{"nctId":"NCT04807894","phase":"PHASE4","title":"Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo","status":"RECRUITING","sponsor":"Maimonides Medical Center","startDate":"2020-11-01","conditions":"Recurrent Urinary Tract Infection, Vaginal Atrophy, Postmenopausal Disorder","enrollment":100},{"nctId":"NCT06291675","phase":"","title":"Gender-Affirming Hormone Therapy and Its Impact on Myocardial Mass and Cardiac Function, Heart, Liver and Pancreatic Fat Content","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2023-03-03","conditions":"Gender Dysphoria, Hormone Therapy Induced Morphologic Change","enrollment":50},{"nctId":"NCT06922318","phase":"PHASE2","title":"The COSMYC Trial (COmbined Suppression of MYC)","status":"RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2025-08-19","conditions":"Metastatic Castration-resistant Prostate Cancer","enrollment":50},{"nctId":"NCT02256865","phase":"EARLY_PHASE1","title":"Hormonal Mechanisms of Sleep Restriction","status":"COMPLETED","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2014-10","conditions":"Insulin Resistance","enrollment":40},{"nctId":"NCT06455969","phase":"PHASE4","title":"Adaptions and Resiliency to Multi-Stressor OpeRations","status":"RECRUITING","sponsor":"Bradley Nindl","startDate":"2024-07-15","conditions":"Musculoskeletal Injury, Hypogonadism","enrollment":120},{"nctId":"NCT06247267","phase":"","title":"The Effect of Sex Steroid Replacement Therapy in the Hypogonadism and Transgender Active-Duty Population","status":"RECRUITING","sponsor":"Walter Reed National Military Medical Center","startDate":"2021-03-09","conditions":"Hypogonadism, Gender Identity Dysphoria","enrollment":75},{"nctId":"NCT05381831","phase":"PHASE4","title":"Natesto Spermatogenesis Reboot","status":"COMPLETED","sponsor":"University of Florida","startDate":"2022-06-01","conditions":"Hypogonadism, Male","enrollment":13},{"nctId":"NCT04833426","phase":"PHASE3","title":"Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomy","status":"RECRUITING","sponsor":"Canisius-Wilhelmina Hospital","startDate":"2022-12-12","conditions":"Prostatic Neoplasms, Hypogonadism, Testosterone Deficiency","enrollment":140},{"nctId":"NCT04456296","phase":"PHASE4","title":"A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism","status":"COMPLETED","sponsor":"Endo Pharmaceuticals","startDate":"2020-06-30","conditions":"Hypogonadism, Hypogonadism, Male, Hypogonadotropic Hypogonadism","enrollment":673},{"nctId":"NCT06351501","phase":"PHASE3","title":"Evaluation of the Effectiveness of Hormonal Treatment in Adolescents Suffering from Gender Dysphoria","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-06-25","conditions":"Gender Dysphoria","enrollment":60},{"nctId":"NCT02432261","phase":"PHASE1","title":"Evaluate the Pharmacokinetics and Gonadotropin Suppression of Nestorone®-Testosterone (NES/T) Combination Gel in Men","status":"COMPLETED","sponsor":"Kimberly Myer","startDate":"2015-04","conditions":"Healthy","enrollment":44},{"nctId":"NCT06393634","phase":"EARLY_PHASE1","title":"Comparing Direct and Indirect Detection Methods of Multiple Routes of Testosterone Administration","status":"COMPLETED","sponsor":"Sports Medicine Research and Testing Laboratory","startDate":"2024-11-27","conditions":"Healthy","enrollment":14},{"nctId":"NCT04558567","phase":"PHASE4","title":"Vogelxo(R) ABPM Study in Hypogandal Men","status":"COMPLETED","sponsor":"Upsher-Smith Laboratories","startDate":"2020-08-28","conditions":"Hypogonadism, Male","enrollment":122},{"nctId":"NCT00645658","phase":"NA","title":"Testosterone Replacement Therapy in Advanced Chronic Kidney Disease","status":"COMPLETED","sponsor":"Palo Alto Veterans Institute for Research","startDate":"2007-08","conditions":"Kidney Failure, Kidney Diseases","enrollment":17},{"nctId":"NCT03339635","phase":"PHASE2","title":"Short-term Testosterone Replacement in Testicular Cancer Survivors","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"2018-12-21","conditions":"Testicular Cancer","enrollment":32},{"nctId":"NCT02418572","phase":"PHASE3","title":"Testosterone TRANSdermal Gel for Poor Ovarian Responders Trial","status":"TERMINATED","sponsor":"Fundacion Dexeus","startDate":"2015-04","conditions":"Infertility, Poor Ovarian Response","enrollment":290},{"nctId":"NCT04717362","phase":"EARLY_PHASE1","title":"The Effects of Natesto For Treatment Of Hypogonadism","status":"WITHDRAWN","sponsor":"Baylor College of Medicine","startDate":"2024-03-01","conditions":"Hypogonadism, Male, Infertility, Male, Testosterone Deficiency","enrollment":""},{"nctId":"NCT00467987","phase":"NA","title":"Effect of Androgel on Atherogenesis in Type 2 Diabetic Males With Hypogonadotrophic Hypogonadism","status":"TERMINATED","sponsor":"University at Buffalo","startDate":"2007-06-01","conditions":"Type 2 Diabetic Male With Hypogonadotrophic Hypogonadism","enrollment":47},{"nctId":"NCT04983940","phase":"PHASE4","title":"Patient Satisfaction After Switching to Oral Testosterone Undecanoate","status":"COMPLETED","sponsor":"University of Miami","startDate":"2021-06-18","conditions":"Testosterone Deficiency","enrollment":41},{"nctId":"NCT00587431","phase":"PHASE2","title":"Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2003-07","conditions":"Prostate Cancer","enrollment":102},{"nctId":"NCT03345797","phase":"PHASE1","title":"Evaluation of Testosterone Nasal Gel in Hypogonadal Boys","status":"TERMINATED","sponsor":"Acerus Biopharma Inc.","startDate":"2018-03-01","conditions":"Hypogonadism","enrollment":8},{"nctId":"NCT01460654","phase":"PHASE2","title":"Testosterone and Alendronate in Hypogonadal Men","status":"TERMINATED","sponsor":"Massachusetts General Hospital","startDate":"2011-10","conditions":"Hypogonadism, Osteopenia, Osteoporosis","enrollment":44},{"nctId":"NCT05825092","phase":"PHASE2","title":"Effects of Early Testosterone Gel Administration on Physical Performance in the Critically Ill","status":"RECRUITING","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2023-07-21","conditions":"Critical Illness","enrollment":600},{"nctId":"NCT03198728","phase":"PHASE3","title":"Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men","status":"COMPLETED","sponsor":"Marius Pharmaceuticals","startDate":"2017-07-05","conditions":"Hypogonadism, Male","enrollment":314},{"nctId":"NCT03678233","phase":"PHASE2","title":"Efficacy of Testosterone Gel to Restore Normal Serum Values of Testosterone During the Acute Phase of Critical Illness in Adult ICU Patients","status":"UNKNOWN","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2019-06-27","conditions":"Hypermetabolism in ICU, Loss of Muscle Mass, Functional Disability After ICU","enrollment":30},{"nctId":"NCT05484167","phase":"PHASE4","title":"Natesto Testosterone Nasal Gel for Hypogonadal Men","status":"WITHDRAWN","sponsor":"University of Utah","startDate":"2023-01-01","conditions":"Erectile Dysfunction, Sexual Dysfunction","enrollment":""},{"nctId":"NCT00694733","phase":"NA","title":"Regulation of Cortisol Metabolism and Fat Patterning","status":"UNKNOWN","sponsor":"Oregon Health and Science University","startDate":"2005-05","conditions":"Obesity, Menopausal Syndrome","enrollment":140},{"nctId":"NCT04274894","phase":"PHASE4","title":"A Study of the Effect of Topical Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism","status":"COMPLETED","sponsor":"AbbVie","startDate":"2020-05-12","conditions":"Hypogonadism","enrollment":246},{"nctId":"NCT04492553","phase":"PHASE2","title":"Gonadal Dysfunction in Male Long-term Survivors of Malignant Lymphoma; Vitality","status":"COMPLETED","sponsor":"Lars Møller Pedersen","startDate":"2021-04-01","conditions":"Hypogonadism","enrollment":7},{"nctId":"NCT04976595","phase":"PHASE4","title":"A Study to Monitor Ambulatory Blood Pressure Monitoring in Hypogonadal Men Treated With Nasal Testosterone Gel","status":"UNKNOWN","sponsor":"Acerus Pharmaceuticals Corporation","startDate":"2021-07-01","conditions":"Hypogonadism","enrollment":218},{"nctId":"NCT00612742","phase":"PHASE3","title":"Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women","status":"COMPLETED","sponsor":"BioSante Pharmaceuticals","startDate":"2008-01","conditions":"Hypoactive Sexual Desire Disorder","enrollment":3656},{"nctId":"NCT01585831","phase":"NA","title":"Study of Psychological and Motor Effects of Testosterone in Adolescents With XXY/Klinefelter Syndrome","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2012-03","conditions":"Klinefelter Syndrome, XXY Syndrome","enrollment":48},{"nctId":"NCT01201863","phase":"PHASE4","title":"Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy","status":"COMPLETED","sponsor":"Craig Hospital","startDate":"2010-09","conditions":"Endocrine Dysfunction, Trauma, Brain Injury","enrollment":46},{"nctId":"NCT01699178","phase":"PHASE3","title":"Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men","status":"COMPLETED","sponsor":"Clarus Therapeutics, Inc.","startDate":"2012-08","conditions":"Male Hypogonadism","enrollment":182},{"nctId":"NCT04831099","phase":"PHASE3","title":"Testosterone Treatment in a Patient With 17β-hydroxysteroid Dehydrogenase Type 3 Deficiency: an N-of-1 Study","status":"UNKNOWN","sponsor":"Erasmus Medical Center","startDate":"2021-06-01","conditions":"Disorder of Sex Development, 46,XY","enrollment":1},{"nctId":"NCT04819204","phase":"NA","title":"Testosterone and Neurovascular Control in Humans","status":"UNKNOWN","sponsor":"Western University, Canada","startDate":"2021-06","conditions":"Healthy","enrollment":20},{"nctId":"NCT04602143","phase":"NA","title":"Effect of Testosterone Pretreatment in POR","status":"COMPLETED","sponsor":"Hanoi Medical University","startDate":"2018-02-16","conditions":"Infertility","enrollment":165},{"nctId":"NCT00112151","phase":"PHASE2","title":"TEAM: Testosterone Supplementation and Exercise in Elderly Men","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2005-01","conditions":"Healthy","enrollment":167},{"nctId":"NCT01533129","phase":"PHASE4","title":"The Effect of Testosterone Replacement on Endothelial Dysfunction, Inflammation and Insulin Resistance in Male Hypogonadotrophic Hypogonadism","status":"COMPLETED","sponsor":"Gulhane School of Medicine","startDate":"2008-08","conditions":"Hypogonadotrophic Hypogonadism","enrollment":106},{"nctId":"NCT03176537","phase":"PHASE4","title":"Periodontal Profile of Hypogonadic Men","status":"WITHDRAWN","sponsor":"Universidade Federal do Paraná","startDate":"2017-05-01","conditions":"Periodontitis, Hypogonadism, Male","enrollment":""},{"nctId":"NCT02147964","phase":"PHASE2","title":"ITT-5 Mechanisms of Spermatogenesis in Man","status":"WITHDRAWN","sponsor":"University of Washington","startDate":"2019-06","conditions":"Gonadotropin Deficiency","enrollment":""},{"nctId":"NCT00405353","phase":"PHASE1, PHASE2","title":"Testosterone Treatment for Multiple Sclerosis","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2002-04","conditions":"Multiple Sclerosis","enrollment":10},{"nctId":"NCT03000127","phase":"PHASE2","title":"Testosterone for Fatigue in Men With MS","status":"WITHDRAWN","sponsor":"University of California, Los Angeles","startDate":"2018-07-01","conditions":"Multiple Sclerosis","enrollment":""},{"nctId":"NCT00114114","phase":"NA","title":"Dose-Response of Gonadal Steroids and Bone Turnover in Older Men","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2004-09","conditions":"Healthy Volunteers","enrollment":177},{"nctId":"NCT02513940","phase":"PHASE4","title":"Influence of Testosterone Administration on Drug-Induced QT Interval Prolongation and Torsades de Pointes","status":"COMPLETED","sponsor":"Indiana University","startDate":"2016-05","conditions":"Long QT Syndrome","enrollment":14},{"nctId":"NCT00365794","phase":"PHASE2","title":"Effects of Testosterone Gel on Carbohydrate and Lipid Metabolism In Elderly Obese Men","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2006-08","conditions":"Aging, Obesity, Insulin Resistance","enrollment":22},{"nctId":"NCT02937740","phase":"PHASE4","title":"Open-Label Study, Evaluating Patient Satisfaction and Symptom Improvement When Treating Male Hypogonadism With Natesto™","status":"COMPLETED","sponsor":"Acerus Pharmaceuticals Corporation","startDate":"2016-10","conditions":"Hypogonadism","enrollment":117},{"nctId":"NCT00799617","phase":"PHASE3","title":"The Testosterone Trials in Older Men","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2009-11","conditions":"Andropause","enrollment":790},{"nctId":"NCT00104572","phase":"PHASE2","title":"Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial.","status":"COMPLETED","sponsor":"National Institute on Aging (NIA)","startDate":"2004-03","conditions":"Hypogonadism, Diabetes, Sarcopenia","enrollment":44},{"nctId":"NCT01403116","phase":"PHASE3","title":"Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men","status":"COMPLETED","sponsor":"Clarus Therapeutics, Inc.","startDate":"2011-07","conditions":"Male Hypogonadism","enrollment":325},{"nctId":"NCT00425568","phase":"","title":"Transdermal Testosterone Gel/Effect on Erection Quality as Measured by DIR","status":"COMPLETED","sponsor":"Lamm, Steven, M.D.","startDate":"2005-12","conditions":"Hypogonadism","enrollment":30},{"nctId":"NCT03619330","phase":"PHASE4","title":"Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism.","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2014-12","conditions":"Hypogonadism, Obesity","enrollment":30},{"nctId":"NCT00805207","phase":"NA","title":"Sex Steroids, Sleep, and Metabolic Dysfunction in Women","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2007-09","conditions":"Polycystic Ovary Syndrome (PCOS), Obstructive Sleep Apnea, Obesity","enrollment":61},{"nctId":"NCT00957801","phase":"PHASE4","title":"Anabolic and Inflammatory Responses to Short-Term Testosterone Administration in Older Men","status":"COMPLETED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2009-03","conditions":"Sarcopenia","enrollment":29},{"nctId":"NCT01686828","phase":"PHASE1, PHASE2","title":"T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone Insulin","status":"COMPLETED","sponsor":"University of Washington","startDate":"2013-06","conditions":"Insulin Resistance, Type 2 Diabetes Mellitus, Obesity","enrollment":53},{"nctId":"NCT00345969","phase":"PHASE3","title":"Exercise and Testosterone Therapy in Elderly Men With Physical Frailty","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2004-11","conditions":"Physical Frailty, Hip Fracture, Elective Hip Replacement","enrollment":25},{"nctId":"NCT00194675","phase":"PHASE4","title":"TRADE-Testosterone Replacement and Dutasteride Effectiveness","status":"COMPLETED","sponsor":"University of Washington","startDate":"2005-03","conditions":"Hypogonadism, Benign Prostatic Hyperplasia","enrollment":53},{"nctId":"NCT02081300","phase":"PHASE3","title":"Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism","status":"COMPLETED","sponsor":"Lipocine Inc.","startDate":"2014-02","conditions":"Male Hypogonadism","enrollment":315},{"nctId":"NCT01327495","phase":"PHASE2, PHASE3","title":"PROS-2 Dose Response Effects of Exogenous Testosterone on the Prostate","status":"COMPLETED","sponsor":"University of Washington","startDate":"2011-10","conditions":"Healthy","enrollment":62},{"nctId":"NCT01228071","phase":"PHASE3","title":"Time to Eugonadal Range, Time to Steady State and Drying Time","status":"COMPLETED","sponsor":"Endo Pharmaceuticals","startDate":"2010-11","conditions":"Male Hypogonadism","enrollment":34},{"nctId":"NCT03281187","phase":"PHASE3","title":"Efficacy and Safety of Testosterone Nasal Gel for Treating Hypogonadism in Men.","status":"UNKNOWN","sponsor":"FBM Industria Brasileira Ltda","startDate":"2018-07-16","conditions":"Hypogonadism","enrollment":228},{"nctId":"NCT02317640","phase":"PHASE1, PHASE2","title":"TRT in Combination With Electrical Stimulation and Standing: Effect on Muscle and Bone in Spinal Cord Injured Males","status":"UNKNOWN","sponsor":"Kessler Foundation","startDate":"2017-03-15","conditions":"Spinal Cord Injury","enrollment":56},{"nctId":"NCT03238092","phase":"PHASE3","title":"Comparison Between Testosterone and Estradiol Over the Homogenization of Follicular Cohort","status":"UNKNOWN","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2017-08","conditions":"Fertility Disorders","enrollment":26},{"nctId":"NCT01377103","phase":"NA","title":"Testosterone Therapy in Heart Failure","status":"WITHDRAWN","sponsor":"Cedars-Sinai Medical Center","startDate":"2011-07","conditions":"Heart Failure, Hypogonadism","enrollment":""},{"nctId":"NCT00287586","phase":"PHASE4","title":"Testosterone Replacement in Older Men and Atherosclerosis Progression","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2004-09","conditions":"Hypogonadism, Atherosclerosis","enrollment":308},{"nctId":"NCT00512707","phase":"PHASE4","title":"Effect of Testosterone in Men With Erectile Dysfunction","status":"COMPLETED","sponsor":"Boston University","startDate":"2006-11","conditions":"Erectile Dysfunction, Testosterone Deficiency, Diabetes","enrollment":140},{"nctId":"NCT00351819","phase":"PHASE2","title":"Effects of Testosterone Replacement on Pain Sensitivity and Pain Perception","status":"COMPLETED","sponsor":"Boston University","startDate":"2006-04","conditions":"Pain, Hypogonadism","enrollment":84},{"nctId":"NCT03118479","phase":"PHASE1","title":"Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism (IHH)","status":"TERMINATED","sponsor":"Massachusetts General Hospital","startDate":"2010-05","conditions":"Hypogonadotropic Hypogonadism, Kallmann Syndrome","enrollment":7},{"nctId":"NCT00438321","phase":"PHASE1","title":"Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome","status":"TERMINATED","sponsor":"Massachusetts General Hospital","startDate":"2006-09","conditions":"Metabolic Syndrome","enrollment":66},{"nctId":"NCT02549690","phase":"NA","title":"Testosterone Gel in Poor Responders Undergoing IVF","status":"WITHDRAWN","sponsor":"Vietnam National University","startDate":"2015-09","conditions":"Infertility","enrollment":""},{"nctId":"NCT00240981","phase":"PHASE4","title":"TOM: Testosterone in Older Men With Sarcopenia","status":"TERMINATED","sponsor":"Boston Medical Center","startDate":"2005-01","conditions":"Sarcopenia, Hypogonadism, Muscular Diseases","enrollment":209},{"nctId":"NCT00586898","phase":"PHASE2","title":"Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2001-07","conditions":"Prostate, Cancer, Hormonal Cycling","enrollment":36},{"nctId":"NCT00839319","phase":"PHASE1, PHASE2","title":"HOP-3 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone","status":"COMPLETED","sponsor":"University of Washington","startDate":"2009-03","conditions":"Healthy Males","enrollment":59},{"nctId":"NCT00254553","phase":"PHASE2","title":"A Study to Test a Measure of Symptoms of Older Men With Low Testosterone On and Off Testosterone Replacement Treatment (P05815)","status":"TERMINATED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2005-07","conditions":"Hypogonadism","enrollment":150},{"nctId":"NCT01386606","phase":"PHASE2","title":"The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone)","status":"COMPLETED","sponsor":"Repros Therapeutics Inc.","startDate":"2011-06","conditions":"Secondary Hypogonadism","enrollment":60},{"nctId":"NCT00706719","phase":"PHASE2","title":"To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone","status":"COMPLETED","sponsor":"Repros Therapeutics Inc.","startDate":"2008-06","conditions":"Secondary Hypogonadism","enrollment":17},{"nctId":"NCT00440440","phase":"PHASE4","title":"Effect of Testosterone Gel Replacement on Fat Mass in Males With Low Testosterone Levels and Diabetes","status":"WITHDRAWN","sponsor":"Diabetes Center of the Southwest","startDate":"2009-08","conditions":"Hypogonadism, Diabetes","enrollment":""},{"nctId":"NCT00848497","phase":"EARLY_PHASE1","title":"Testosterone for Penile Rehabilitation After Radical Prostatectomy","status":"TERMINATED","sponsor":"Mohit Khera","startDate":"2007-11","conditions":"Hypogonadism, Erectile Dysfunction","enrollment":3},{"nctId":"NCT01292785","phase":"","title":"Effects of Sex Steroid Hormones on Human Brain Function, Structure and Connectivity","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2011-01","conditions":"Gender Identity Disorder","enrollment":80},{"nctId":"NCT01689896","phase":"PHASE4","title":"Testosterone and Pain Sensitivity","status":"WITHDRAWN","sponsor":"Johns Hopkins University","startDate":"2012-08","conditions":"Low Testosterone, Hypogonadism, Pain","enrollment":""},{"nctId":"NCT00141492","phase":"PHASE2","title":"Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes","status":"COMPLETED","sponsor":"Solvay Pharmaceuticals","startDate":"2004-10","conditions":"Type 2 Diabetes, Hypogonadism","enrollment":""},{"nctId":"NCT00229593","phase":"PHASE1","title":"NES Gel-1, To Evaluate Nestorone Gel in Combination With Testosterone Gel","status":"COMPLETED","sponsor":"University of Washington","startDate":"2005-09","conditions":"Contraception","enrollment":140},{"nctId":"NCT01123278","phase":"PHASE4","title":"Testosterone Replacement in Metabolic Syndrome and Inflammation","status":"COMPLETED","sponsor":"University of Roma La Sapienza","startDate":"2004-01","conditions":"Hypogonadism, Metabolic Syndrome, Obesity","enrollment":82},{"nctId":"NCT01893281","phase":"PHASE4","title":"The Effect of Testosterone Topical Solution (LY900011) in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2013-07","conditions":"Hypogonadism","enrollment":78},{"nctId":"NCT01993225","phase":"PHASE3","title":"A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%","status":"COMPLETED","sponsor":"Repros Therapeutics Inc.","startDate":"2014-01","conditions":"Secondary Hypogonadism","enrollment":120},{"nctId":"NCT01993212","phase":"PHASE3","title":"A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%","status":"COMPLETED","sponsor":"Repros Therapeutics Inc.","startDate":"2014-01","conditions":"Secondary Hypogonadism","enrollment":120},{"nctId":"NCT00969163","phase":"PHASE1","title":"A Study to Investigate Biomarkers of Skin Androgenization Following Testosterone Administration (0000-015)(COMPLETED).","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2004-10","conditions":"Skin Androgenization","enrollment":30},{"nctId":"NCT01270841","phase":"PHASE2","title":"Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism","status":"COMPLETED","sponsor":"Repros Therapeutics Inc.","startDate":"2011-01","conditions":"Secondary Hypogonadism","enrollment":83},{"nctId":"NCT02110368","phase":"PHASE3","title":"Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions","status":"COMPLETED","sponsor":"Amneal Pharmaceuticals, LLC","startDate":"2014-03","conditions":"Primary Hypogonadism, Hypogonadotropic Hypogonadism","enrollment":32},{"nctId":"NCT02171390","phase":"PHASE4","title":"Endothelial Dysfunction, Inflammation and Insulin Resistance in Congenital Hypogonadism and Effect of Testosteron Replacement Therapy","status":"COMPLETED","sponsor":"Gulhane School of Medicine","startDate":"2008-08","conditions":"Hypogonadotrophic Hypogonadism","enrollment":130},{"nctId":"NCT00515112","phase":"PHASE2","title":"Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer","status":"TERMINATED","sponsor":"University of Chicago","startDate":"2007-07","conditions":"Prostate Cancer","enrollment":6}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"CONFUSIONAL STATE"},{"count":2,"reaction":"FATIGUE"},{"count":1,"reaction":"AGITATION"},{"count":1,"reaction":"ASTHENIA"},{"count":1,"reaction":"AXILLARY VEIN THROMBOSIS"},{"count":1,"reaction":"BASAL CELL CARCINOMA"},{"count":1,"reaction":"BLOOD TESTOSTERONE DECREASED"},{"count":1,"reaction":"CONVULSION"},{"count":1,"reaction":"COUGH"},{"count":1,"reaction":"DISORIENTATION"}],"_approvalHistory":[],"publicationCount":360,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Testosterone gel","Androgel"],"phase":"marketed","status":"active","brandName":"Androgel (Testosterone Gel)","genericName":"Androgel (Testosterone Gel)","companyName":"National Institute on Aging (NIA)","companyId":"national-institute-on-aging-nia","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Androgel delivers testosterone transdermally to replace deficient testosterone levels in hypogonadal men. Used for Hypogonadism (testosterone deficiency) in adult males.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}